SEC CIK 1589725
Thackray Helen M.
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BCRXview stock → | 377,318 | 2025-03-31 |
| CBIOview stock → | 183,115 | 2021-01-20 |
Position History — BCRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BCRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-03-31 | Tax withholding | 7,525 | $7.50 | 377,318 |
| 2024-12-19 | Grant / award (derivative) | 260,950 | $0.00 | 260,950 |
| 2024-12-19 | Tax withholding | 6,096 | $7.39 | 384,843 |
| 2024-12-19 | Grant / award | 125,950 | $0.00 | 390,939 |
| 2024-12-14 | Tax withholding | 7,150 | $7.53 | 264,989 |
| 2024-05-14 | Open-market buy | 30,000 | $5.86 | 272,139 |
| 2024-03-31 | Tax withholding | 7,525 | $5.08 | 242,139 |
| 2023-12-19 | Tax withholding | 5,580 | $6.05 | 249,664 |
| 2023-12-14 | Grant / award (derivative) | 238,000 | $0.00 | 238,000 |
| 2023-12-14 | Grant / award | 51,000 | $0.00 | 258,275 |
| 2023-12-14 | Tax withholding | 3,031 | $6.43 | 255,244 |
| 2023-04-03 | Open-market sale | 7,000 | $8.29 | 207,275 |
| 2022-12-19 | Grant / award (derivative) | 238,000 | $0.00 | 238,000 |
| 2022-12-19 | Grant / award | 81,000 | $0.00 | 214,275 |
| 2022-12-15 | Open-market sale | 3,125 | $10.89 | 133,275 |
| 2022-04-01 | Open-market sale | 7,600 | $16.20 | 136,400 |
| 2021-12-14 | Grant / award (derivative) | 205,000 | $0.00 | 205,000 |
| 2021-12-14 | Grant / award | 44,000 | $0.00 | 144,000 |
| 2021-03-31 | Grant / award (derivative) | 400,000 | $0.00 | 400,000 |
| 2021-03-31 | Grant / award | 100,000 | $0.00 | 100,000 |
| 2020-05-12 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2019-09-20 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.